Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Preleukemic disorders].

Y Yoshida1, S Oguma, H Uchino

  • 11st Dept. of Internal Medicine, Faculty of Medicine, Kyoto University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Japanese clinical statistical data of patients with refractory anemia].

Nihon rinsho. Japanese journal of clinical medicine·1992
Same author

[A case of small adenocarcinoma of the lung with giant bullae].

Kyobu geka. The Japanese journal of thoracic surgery·1992
Same author

Report of a patient with POEMS/Takatsuki/Crow-Fukase syndrome associated with focal spinal pachymeningeal amyloidosis.

Cancer·1992
Same author

Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study.

Leukemia research·1992
Same author

[A successful treatment of coronary arteriovenous fistula with Symbas procedure].

Kyobu geka. The Japanese journal of thoracic surgery·1992
Same author

[Tuberculosis epidemic in a mental hospital].

[Nihon koshu eisei zasshi] Japanese journal of public health·1991
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Myelodysplastic syndromes (MDS) are a group of blood disorders that can lead to acute nonlymphocytic leukemia. This review covers MDS origins, progression, and how they cause leukemia.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Hematopoietic disorders and immunodeficiency states increase the risk of acute nonlymphocytic leukemia.
  • Previously termed refractory anemia or preleukemia, these conditions are now classified as myelodysplastic syndromes (MDS).

Purpose:

  • To review updated knowledge on myelodysplastic syndromes (MDS).
  • Emphasis on clonal origin, natural history, and leukemogenesis mechanisms.

Summary:

  • Myelodysplastic syndromes (MDS) encompass a range of hematopoietic disorders with pre-leukemic potential.
  • The review focuses on the clonal nature of MDS, its progression over time, and the biological pathways leading to leukemia development.
  • Understanding these aspects is crucial for diagnosing and managing MDS patients.

Related Experiment Videos

Impact:

  • Provides a concise overview of current understanding of MDS.
  • Highlights key areas for future research in leukemogenesis.
  • Aids clinicians in recognizing and managing patients at risk for leukemia.